L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
Abstract 18F-FDG PET/CT has been used as an indicator of chemotherapy effects, but cancer cells can remain even when no FDG uptake is detected, indicating the importance of exploring other metabolomic pathways. Therefore, we explored the amino acid metabolism, including L-type amino acid transporter...
Main Authors: | Miku Sato, Narumi Harada-Shoji, Takafumi Toyohara, Tomoyoshi Soga, Masatoshi Itoh, Minoru Miyashita, Hiroshi Tada, Masakazu Amari, Naohiko Anzai, Shozo Furumoto, Takaaki Abe, Takashi Suzuki, Takanori Ishida, Hironobu Sasano |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80668-5 |
Similar Items
-
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer
by: Haruhiko Shindo, et al.
Published: (2021-08-01) -
Nutritional Characteristics and Functions of D-Amino Acids in the Chicken
by: Shozo Tomonaga, et al.
Published: (2020-01-01) -
Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer
by: Xue Zhao, et al.
Published: (2023-03-01) -
Amino acid-based reoxidants for aminohydroxylation: application to the construction of amino acid-amino alcohol conjugates.
by: Donohoe, T, et al.
Published: (2011) -
Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective
by: Sangjon Pae, et al.
Published: (2022-12-01)